Trade CADL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Candel Therapeutics, Inc. (CADL) is trading at US$9.27, down 5.21% today as of Oct 13, 16:00 EDT. The company has a market capitalisation of US$1B. Over the past 52 weeks, CADL has traded between US$4.35 and US$14.00. On Syfe you can trade CADL with $0 commission and add it to your watchlist.
| Previous close | US$9.78 |
|---|---|
| Market cap | US$1B |
| 52-week range | US$4.35 – US$14.00 |
| Volume | 1.13M |
| Exchange | US |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Year: 2021
Candel Therapeutics Insider Sold Shares Worth $3,160,783, According to a Recent SEC Filing
Sep 14, 8:25 AM · MT Newswires
BofA Adjusts Price Target on Candel Therapeutics to $12 From $9
Aug 14, 11:40 AM · MT Newswires
Candel Therapeutics Q2 Loss Widens
Aug 13, 12:48 PM · MT Newswires
--Earnings Flash (CADL) Candel Therapeutics Posts Q2 Net Loss $0.52 a Share, vs. FactSet Est of $0.21 Loss
Aug 13, 12:24 PM · MT Newswires
Candel Therapeutics, Inc. (CADL) stock is trading at US$9.27, -5.21% from the previous close of US$9.78.
The market cap for Candel Therapeutics, Inc. (CADL) stock is approximately US$1B.
The 52-week high for Candel Therapeutics, Inc. (CADL) stock is US$14.00.
The 52-week low for Candel Therapeutics, Inc. (CADL) stock is US$4.35.
Candel Therapeutics, Inc. (CADL) does not currently pay a dividend.
Stay on top of CADL
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
